<
 / Physicians

Newsroom

Resolution: The shortage of sodium phosphate 3 mmol/mL injection has resolved and NH pharmacy now has access to an adequate ongoing supply.

The Issue: Due to unprecedented demand for propofol across Canada throughout the waves of the COVID-19 pandemic, Health Canada previously approved the importation of US-labelled propofol 10 mg/mL X 100 mL vials from Sagent Pharmaceuticals (Omega) as a national safety stock.

The issue: EPINEPHrine 1 mg/10 mL pre-filled syringes (PFS) are in short supply from the sole source vendor in Canada (Pfizer) and likely to go on backorder soon. NH has approximately 5 to 6 weeks of stock in pharmacies and available as wardstock.

The issue: Voriconazole 200 mg injectable is in short supply from the sole source vendor in Canada, Fresenius Kabi. This is a fairly low use item in NH, but remaining supply will need to be conserved in order to prevent any stock outs.

The Issue: Fresenius Kabi has changed the appearance of vial labelling and colour of vial caps for their heparin 5000 units/0.5 mL vials in order to improve safety by differentiating from other look-alike products.

NH Laboratories offer support to all physicians in their daily diagnosis and monitoring of patients’ conditions. We recognize that BNP is a useful tool in predicting prognoses in patients with heart failure.